Author

K. Fujiyama

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Cancer Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:mouse· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Approach:mechanistic / dynamical model· 1 Research Focus:protein folding & dynamics· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

A. Du· 1 shared H. Guo· 1 shared H. Kajiura· 1 shared H. Osada· 1 shared K. Ikuta· 1 shared K. Kinugasa· 1 shared K. L. Mayer· 1 shared K. Watanabe· 1 shared

Activity by Year

2019-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 12 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. Du

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologybioRxivPreprintMay 31, 2022

Impact of glycoengineering and immunogenicity on the anti-cancer activity of a plant-made lectin-Fc fusion protein

M. Dent, K. L. Mayer, N. Verjan Garcia…·N. Matoba

This study shows that glycoengineering AvFc to remove plant glycans enhances its anti-cancer activity by improving Fc receptor binding and ADCC, while being unaffected by anti-drug antibodies.

DOI 10.1101/2022.05.31.494188

mouseproteomics

𝕏 PostBluesky

BiochemistrybioRxivFeb 1, 2021

Molecular basis for two stereoselective Diels-Alderases that produce decalin skeletons

K. Fujiyama, N. Kato, S. Re…·S. Nagano

This study determines the molecular mechanisms of two Diels-Alderases that produce enantiomeric decalin scaffolds through structural and computational analyses.

DOI 10.1002/anie.202106186

structural biologyexperimental assay

𝕏 PostBluesky

MicrobiologybioRxivDec 18, 2019

Fully Human Monoclonal Antibodies Effectively Neutralizing Botulinum Neurotoxin Serotype B

T. Matsumura, S. Amatsu, R. Misaki…·Y. Fujinaga

This study develops fully human monoclonal antibodies against BoNT/B that show potent neutralization activity and broad subtype coverage, with therapeutic and prophylactic effects in mice.

DOI 10.3390/toxins12050302

mouseexperimental assay

𝕏 PostBluesky